Recent Study on Design and Development of a Wearable Device to Monitor Vital Signs of Preggers

2021 ◽  
pp. 151-158
Author(s):  
L. K. Hema ◽  
R. Mohana Priya ◽  
K. L. Shunmuganathan ◽  
S. Velmurugan
Keyword(s):  
Vital Signs ◽  
Wearable Device ◽  
Design And Development

scholarly journals Factors to Consider in the Use of Vital Signs Wearables to Minimize Contact With Stable COVID-19 Patients: Experience of Its Implementation During the Pandemic

2021 ◽  
Vol 3 ◽  
Author(s):  
Esther Monica Pei Jin Fan ◽  
Shin Yuh Ang ◽  
Ghee Chee Phua ◽  
Lee Chen Ee ◽  
Kok Cheong Wong ◽  
...  
Keyword(s):  
Personal Protective Equipment ◽  
Vital Signs ◽  
Healthcare Facility ◽  
Wearable Device ◽  
Protective Equipment ◽  
Healthcare Industry ◽  
Patient Contact ◽  
Vital Signs Monitoring ◽  
Number Of Patients ◽  
Patients Experience

The COVID-19 pandemic has created a huge burden on the healthcare industry worldwide. Pressures to increase the isolation healthcare facility to cope with the growing number of patients led to an exploration of the use of wearables for vital signs monitoring among stable COVID-19 patients. Vital signs wearables were chosen for use in our facility with the purpose of reducing patient contact and preserving personal protective equipment. The process of deciding on the wearable solution as well as the implementation of the solution brought much insight to the team. This paper presents an overview of factors to consider in implementing a vital signs wearable solution. This includes considerations before deciding on whether or not to use a wearable device, followed by key criteria of the solution to assess. With the use of wearables rising in popularity, this serves as a guide for others who may want to implement it in their institutions.

scholarly journals Continuous monitoring of health data with a wearable device in pediatric patients undergoing chemotherapy for cancer – a feasibility pilot study

2021 ◽  
Author(s):  
Brack Eva ◽  
Koenig Christa ◽  
Roessler Jochen ◽  
Ammann Roland A.
Keyword(s):  
Pilot Study ◽  
Continuous Monitoring ◽  
Pediatric Patients ◽  
Clinical Symptoms ◽  
Vital Signs ◽  
Ethics Committees ◽  
Health Data ◽  
Wearable Device ◽  
Delayed Treatment ◽  
Patient Will

Abstract Pediatric patients with cancer are at high risk for severe infections and delayed treatment increases mortality. Infections can trigger changes of vital signs long before clinical symptoms arise. Continuous recording may detect such changes earlier than discrete measurements. This is the protocol for an investigator-initiated, single-center observational pilot study on the feasibility of continuous monitoring of health data with a wearable device (WD) in pediatric patients undergoing chemotherapy of cancer. A total of 20 patients will be included, including at least 4 patients <6 years. Each patient will wear the WD for 14 days and we expect study duration of three to four months. The protocol had been registered at www.clinicaltrials.com (NCT04134429) and was approved by the local Ethics Committees (Ethikkommission der Universitätskinderkliniken Bern, “Gesuch 1912”, Kantonale Ethikkommission Bern, BASEC-No.: 2019-01919).

scholarly journals Continuous recording of vital signs with a wearable device in pediatric patients undergoing chemotherapy for cancer—an operational feasibility study

2021 ◽  
Author(s):  
Christa Koenig ◽  
Roland A. Ammann ◽  
Claudia E. Kuehni ◽  
Jochen Roessler ◽  
Eva Brack
Keyword(s):  
Heart Rate ◽  
Pediatric Patients ◽  
Clinical Symptoms ◽  
Vital Signs ◽  
Wearable Device ◽  
Continuous Recording ◽  
Patient Specific ◽  
Specific Goal ◽  
Severe Infections ◽  
Age Range

Abstract Purpose Pediatric patients with cancer are at high risk for severe infections. Infections can trigger changes of vital signs long before clinical symptoms arise. Continuous recording may detect such changes earlier than discrete measurements. We aimed to assess the feasibility of continuous recording of vital signs by a wearable device (WD) in pediatric patients undergoing chemotherapy for cancer. Methods In this prospective, observational single-center study, pediatric patients under chemotherapy wore the Everion® WD for 14 days. The predefined patient-specific goal was heart rate recorded in good quality during ≥18/24 h per day, on ≥7 consecutive days. The predefined criterion to claim feasibility was ≥15/20 patients fulfilling this patient-specific goal. Results Twenty patients were included (median age, 6 years; range, 2–16). Six patients aged 3–16 years fulfilled the patient-specific goal. Quality of heart rate recording was good during 3992 of 6576 (61%) hours studied and poor during 300 (5%) hours, and no data was recorded during 2284 (35%) hours. Eighteen of 20 participants indicated that this WD is acceptable to measure vital signs in children under chemotherapy. Conclusion The predefined feasibility criterion was not fulfilled. This was mainly due to important compliance problems and independent of the WD itself. However, continuous recording of vital signs was possible across a very wide age range in pediatric patients undergoing chemotherapy for cancer. We recommend to study feasibility in the Everion® again, plus in further WDs, applying measures to enhance compliance. Trial registration ClinicalTrials.gov (NCT04134429) on October 22, 2019.

scholarly journals Design and Development of a Wearable Device to Monitor Vital Signs of Preggers

2019 ◽  
Vol 9 (2) ◽  
pp. 5212-5214
Keyword(s):  
Health Monitoring ◽  
Rural Areas ◽  
Vital Signs ◽  
Preventive Measure ◽  
Health Condition ◽  
The Body ◽  
Wearable Device ◽  
Optimal Care ◽  
Wearable Systems ◽  
Expectant Mothers

As the growth of the technology rises day to day but still we cannot able to overlook any wearable device which is the friendliest one for pregnant women. Our proposed system is a wearable device which monitors the health condition of expectant mothers’ and transmits data to the respective physician especially in rural areas. With these kind of real time wearable systems, doctors are able to provide higher quality medical services and more personalized healthcare to these women. This health monitoring system would allow a pregnant woman to interact with a physician with almost full functional capability. Preventive measure taken by continuoushealth monitoringof patient from early stages and guidance to avoid prenatal risks is the prime objective of this system. It is only applicable after 16 weeks of pregnancy. The health monitoring device constantly measures the body temperature and heartbeat of the womb and whenever there are fluctuations from the normal value it sends the information to gynecologist at remote place through GSM.The usage of these advanced technologies for pregnant women’s care facilitates optimal care to them and thereby pregnancy period mortality can be reduced substantially.

Sign in / Sign up

Export Citation Format

Share Document